cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ironwood Pharmaceuticals Inc
5 own
12 watching
Current Price
$8.31
$0.25
(3.1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,106.26M
52-Week High
52-Week High
15.70000
52-Week Low
52-Week Low
7.53000
Average Volume
Average Volume
2.11M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
4.0198
iconMarket Capitalization2,106.26M
icon52-Week High15.70000
icon52-Week Low7.53000
iconAverage Volume2.11M
iconDividend Yield--
iconP/E Ratio4.0198
What does the Ironwood Pharmaceuticals Inc do?
Ironwood Pharmaceuticals, Inc., a commercial biotechnology company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Constella name in the European Union; and lesinurad for the treatment of hyperuricemia associated with uncontrolled gout under ZURAMPIC and DUZALLO names. It has collaboration agreements with Allergan plc and AstraZeneca AB to develop and commercialize linaclotide for the treatment of IBS-C, CIC, and other GI conditions in North America, China, Hong Kong, and Macau; and license agreement with Astellas Pharma Inc. to develop and commercialize linaclotide for the treatment of IBS-C, chronic constipation, and other GI conditions in Japan. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Ironwood Pharmaceuticals Inc make?
News & Events about Ironwood Pharmaceuticals Inc.
Business Wire
10 months ago
Ironwood Pharmaceuticals, Inc. (Ironwood) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, today...
Business Wire
10 months ago
Ironwood Pharmaceuticals, Inc. (Ironwood) (Nasdaq: IRWD), a GI-focused healthcare company, and VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, today...
Business Wire
1 year ago
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for LINZESS (linaclotide) for the treatment of children and adolescents ages...
Zolmax
1 year ago
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD Get Rating) CEO Thomas A. Mccourt sold 110,962 shares of the companys stock in a transaction dated Thursday, January 5th. The stock was sold at an average price of $12.07, for a total transaction of $1,339,311.34. Following the completion of the ...
Frequently Asked Questions
Frequently Asked Questions
What is Ironwood Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Ironwood Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Ironwood Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Ironwood Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ironwood Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Ironwood Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Ironwood Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ironwood Pharmaceuticals Inc?
plus_minus_icon
What percentage is Ironwood Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ironwood Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$8.31
$0.25
(3.1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00